Grace Therapeutics, Inc. (GRCE) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 2K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -2K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 3.01M | 3.36M | 3.53M | 3.09M | 4.53M | 5.33M | 4.83M | 6.79M | 4.43M | 4.03M | 2.83M | 5.9M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 308.59K | 2.72M | 2.73M | 2.13M | 2.2M | 2.17M | 1.85M | 3.08M | 2.09M | 2.12M | 2.21M | 2.48M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 420K | 633.92K | 792.21K | 955K | 2.33M | 3.16M | 2.98M | 3.7M | 2.29M | 1.91M | 622.95K | 1.45M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 1000K | 2.74K | 1.39K | 2K | 2.85K | 1.44K | 2K | 1.37K | 47.49K | 0 | 1.35K | 1000K |
| Operating Income | -3.01M | -3.36M | -3.53M | -3.09M | -4.53M | -5.33M | -4.83M | -6.79M | -4.43M | -4.03M | -2.83M | -5.9M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 33.6% | 36.91% | 26.99% | 54.48% | -2.37% | -32.06% | -70.52% | -15.03% | 91.4% | 29.28% | 59.54% | 3.12% |
| EBITDA | -3.01M | -3.36M | -3.53M | -3.09M | -4.53M | -5.32M | -4.83M | -6.79M | -4.38M | -4.03M | -2.83M | -5.89M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 33.6% | 36.96% | 26.99% | 54.5% | -3.42% | -32.03% | -70.62% | -15.19% | 91.49% | 29.14% | 59.93% | -0.27% |
| D&A (Non-Cash Add-back) | 2K | 4.12K | 1.39K | 2K | 2.85K | 2.88K | 2K | 1.37K | 47.49K | 1.32K | 2.71K | 9.27K |
| EBIT | -3.01M | -3.36M | -3.53M | -3.09M | -4.53M | -5.33M | -4.83M | -6.79M | -4.43M | -4.03M | -2.83M | -3.93M |
| Net Interest Income | 138K | 233.26K | 172K | 205K | 167K | 138K | 172K | 235K | 249K | 316K | 212K | 134K |
| Interest Income | 138K | 233.26K | 172K | 205K | 167K | 138K | 172K | 235K | 249K | 316K | 212K | 134K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 132K | 183.87K | 2.22M | -272K | 3.99M | -1.52M | 547K | 2.22M | -1.07M | 588.52K | -2.2M | 188.12K |
| Pretax Income | -2.88M | -3.18M | -1.31M | -3.36M | -544.01K | -6.85M | -4.28M | -4.57M | -5.5M | -3.44M | -5.04M | -5.71M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | -1.7M | 0 | 0 | 0 | -1.45M | -870.04K | -852K | -990.16K | -1.21M | -275.7K | -603.99K | -382.86K |
| Effective Tax Rate % | 59.09% | 0% | 0% | 0% | 266.49% | 12.71% | 19.89% | 21.67% | 21.92% | 8% | 11.99% | 6.7% |
| Net Income | -1.18M | -3.18M | -1.31M | -3.36M | 905.73K | -5.98M | -3.43M | -3.58M | -4.3M | -3.17M | -4.43M | -5.33M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -230.06% | 46.84% | 61.88% | 6.07% | 121.08% | -88.54% | 22.57% | 32.84% | 89.08% | 39.35% | 34.4% | 8.51% |
| Net Income (Continuing) | -1.18M | -3.18M | -1.31M | -3.36M | 905.73K | -5.98M | -3.43M | -3.58M | -4.3M | -3.17M | -4.43M | -5.33M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.07 | -0.19 | -0.08 | -0.29 | 0.06 | -0.52 | -0.40 | -0.33 | -0.42 | -0.28 | -0.59 | -0.72 |
| EPS Growth % | -213.6% | 63.46% | 79.45% | 12.12% | 115.4% | -85.71% | 32.2% | 54.17% | 92.06% | 60% | 35.16% | 8.86% |
| EPS (Basic) | -0.07 | -0.19 | -0.08 | -0.29 | 0.06 | -0.52 | -0.40 | -0.33 | -0.42 | -0.28 | -0.59 | -0.72 |
| Diluted Shares Outstanding | 16.51M | 16.93M | 15.92M | 15.92M | 14.01M | 11.51M | 11.51M | 10.93M | 10.23M | 11.51M | 7.55M | 7.44M |
| Basic Shares Outstanding | 16.51M | 16.93M | 15.92M | 15.92M | 14.01M | 11.51M | 11.51M | 10.93M | 10.23M | 11.51M | 7.55M | 7.44M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |